Who
Douglas W. Pagan
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Kailera Therapeutics; Chief Financial Officer, Dicerna Pharmaceuticals; Director, Alaunos Therapeutics; Chief Financial Officer, Paratek Pharmaceuticals.
In numbers
- Trades disclosed
- 58
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $698K
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 4 Feb 2015
- Last trade
- 16 Apr 2026
- Last filed
- 20 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Apr 2026filed 20 Apr 2026 | KLRA Kailera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 16 Apr 2026filed 20 Apr 2026 | KLRA Kailera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 16 Apr 2026filed 20 Apr 2026 | KLRA Kailera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 16 Apr 2026filed 20 Apr 2026 | KLRA Kailera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —20,475 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —6,150 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —95,650 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —36,900 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticals | SEC FORM 4 Code U | $297K7,775 at $38.25 | filing |
| 15 Dec 2021filed 17 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —2,050 at $0.00 | filing |
| 15 Dec 2021filed 17 Dec 2021 | Dicerna Pharmaceuticals | SEC FORM 4 Code M | —2,050 | filing |
| 15 Dec 2021filed 17 Dec 2021 | Dicerna Pharmaceuticals | SEC FORM 4 Code F | $23K602 at $38.05 | filing |
| 15 Jun 2021filed 17 Jun 2021 | Dicerna Pharmaceuticals | SEC FORM 4 Code M | —6,825 | filing |
| 15 Jun 2021filed 17 Jun 2021 | Dicerna Pharmaceuticals | SEC FORM 4 Code F | $72K2,004 at $35.74 | filing |
| 15 Jun 2021filed 17 Jun 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —6,825 at $0.00 | filing |
| 12 Jan 2021filed 12 Jan 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —8,200 at $0.00 | filing |
| 12 Jan 2021filed 12 Jan 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —36,900 at $0.00 | filing |
| 1 Jun 2020filed 2 Jun 2020 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —27,300 at $0.00 | filing |
| 1 Jun 2020filed 2 Jun 2020 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —95,650 at $0.00 | filing |
| 31 Dec 2019filed 3 Jan 2020 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,281 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.